GSTP1 and cancer: Expression, methylation, polymorphisms and signaling

J Cui, G Li, J Yin, L Li, Y Tan… - International …, 2020 - spandidos-publications.com
Abstract Glutathione S‑transferase Pi (GSTP1) is an isozyme encoded by the GST pi gene
that plays an important regulatory role in detoxification, anti‑oxidative damage, and the …

Prognostic DNA methylation markers for prostate cancer

SH Strand, TF Orntoft, KD Sorensen - International journal of molecular …, 2014 - mdpi.com
Prostate cancer (PC) is the most commonly diagnosed neoplasm and the third most
common cause of cancer-related death amongst men in the Western world. PC is a clinically …

Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns

X Yang, L Gao, S Zhang - Briefings in bioinformatics, 2017 - academic.oup.com
Abnormal DNA methylation is an important epigenetic regulator involving tumorigenesis.
Deciphering cancer common and specific DNA methylation patterns is essential for us to …

DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer

C Haldrup, K Mundbjerg, EM Vestergaard… - Journal of Clinical …, 2013 - ascopubs.org
Purpose Diagnostic and prognostic tools for prostate cancer (PC) are suboptimal, causing
overtreatment of indolent PC and risk of delayed treatment of aggressive PC. Here, we …

GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications

F Martignano, G Gurioli, S Salvi, D Calistri… - Disease …, 2016 - Wiley Online Library
GSTP1 belongs to the GSTs family, a group of enzymes involved in detoxification of
exogenous substances and it also plays an important role in cell cycle regulation. Its …

The role of cell-free DNA in cancer treatment decision making

A Telekes, A Horváth - Cancers, 2022 - mdpi.com
Simple Summary The aim of this review is to evaluate the present status of the use of cell-
free DNA and its fraction of circulating tumor DNA (ctDNA) because this year July 2022, an …

Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy

H Kristensen, C Haldrup, S Strand, K Mundbjerg… - Clinical Cancer …, 2014 - AACR
Purpose: Available tools for prostate cancer diagnosis and prognosis are suboptimal and
novel biomarkers are urgently needed. Here, we investigated the regulation and biomarker …

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies

C Haldrup, AL Pedersen, N Øgaard… - Molecular …, 2018 - Wiley Online Library
Current diagnostic and prognostic tools for prostate cancer (PC) are suboptimal, leading to
overdiagnosis and overtreatment. Aberrant promoter hypermethylation of specific genes has …

DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy

A Paziewska, M Dabrowska, K Goryca… - British journal of …, 2014 - nature.com
Background: We analysed critically the potential usefulness of RNA-and DNA-based
biomarkers in supporting conventional histological diagnostic tests for prostate carcinoma …

Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer …

Y Liang, PKF Chiu, Y Zhu, CYP Wong, Q Xiong… - PLoS …, 2022 - journals.plos.org
Prostate cancer is the most inheritable cancer with approximately 42% of disease risk
attributed to inherited factors by studies of twins, indicating the importance of additional …